Thus, further in vitro and in vivo studies should be done to identify the mechanisms involved in the pathogenesis of PCOS and progesterone treatment, especially in the case of obesity, by focusing on the effects of FSH, LH/FSH and DHEA levels and Hb-EGF expression. The gene discussed is PLOD1; the disease is obesity due to melanocortin 4 receptor deficiency.